Resistance to insecticides has become a critical issue in pest management and it is particularly chronic in the control of human disease vectors. The gravity of this situation is being exacerbated since there has not been a new insecticide class produced for over twenty years. Reasoned strategies have been developed to limit resistance spread but have proven difficult to implement in the field. Here we propose a new conceptual strategy based on inhibitors that preferentially target mosquitoes already resistant to a currently used insecticide. Application of such inhibitors in rotation with the insecticide against which resistance has been selected initially is expected to restore vector control efficacy and reduce the odds of neo-resistance. We validated this strategy by screening for inhibitors of the G119S mutated acetylcholinesterase-1 (AChE1), which mediates insensitivity to the widely used organophosphates (OP) and carbamates (CX) insecticides. PyrimidineTrione Furan-substituted (PTF) compounds came out as best hits, acting biochemically as reversible and competitive inhibitors of mosquito AChE1 and preferentially inhibiting the mutated form, insensitive to OP and CX. PTF application in bioassays preferentially killed OP-resistant Culex pipiens and Anopheles gambiae larvae as a consequence of AChE1 inhibition. Modeling the evolution of frequencies of wild type and OP-insensitive AChE1 alleles in PTF-treated populations using the selectivity parameters estimated from bioassays predicts a rapid rise in the wild type allele frequency. This study identifies the first compound class that preferentially targets OP-resistant mosquitoes, thus restoring OP-susceptibility, which validates a new prospect of sustainable insecticide resistance management.
Citation: Alout H, Labbé P, Berthomieu A, Djogbénou L, Leonetti J-P, Fort P, et al. (2012) Novel AChE Inhibitors for Sustainable Insecticide Resistance Management. PLoS ONE 7(10): e47125. doi:10.1371/journal.pone.0047125
Editor: Basil Brooke, National Institute for Communicable Diseases/NHLS, South Africa
Received: May 14, 2012; Accepted: September 10, 2012; Published: October 8, 2012
Copyright: © Alout et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work received financial support by the ANR (Agence Nationale pour la Recherche), Morevol Santé-Environnement (Ministère Délégué à la Recherche) and Contribution 2012-XXX of the Institut des Sciences de L’Evolution de Montpellier (UMR (Unité Mixte de Recherche) CNRS (Centre National de la Recherche Scientifique) - UM2 5554). HA was supported by ANR (3- year grant) and CNRS (one-year SPV grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Pending is an international patent entitled “Use of compounds derived pyrimidinetrione as acetylcholinesterase inhibitors, composition containing said derivatives, and the uses thereof”, registered 10 February 2006 under the number 11/816,032. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Organophosphates (OP), carbamates (CX) and pyrethroids represent, by number, 80% of insecticides used in the field (reviewed in ). These molecules act on the nervous system through inhibition of acetylcholinesterase (OP and CX) or voltage-gated sodium channels (pyrethroids and DDT). The major setback of insecticide use is the selection for resistance, observed not only in the targeted pests but also in many other sympatric species , . At the physiological level, resistance is a consequence of either increased detoxication or modification of the insecticide target, the latter often resulting in very high insensitivity , . However both mechanisms may be responsible for vector control failure and have to be addressed by insecticide resistance management strategies. Resistance has spread to such an extent, particularly in mosquito vector populations, that it now represents a critical issue for the control of the diseases they transmit, e.g. malaria, dengue, filariasis, West Nile fever or Japanese encephalitis .
Sustainable strategies to counter resistance spread aim at maintaining resistant alleles at frequencies low enough so that current insecticides remain efficient even at moderate doses. As an example, the reasoned use of insecticides through rotations or mosaic applications takes advantage of the pleiotropic cost (i.e. the reduced fitness of resistant vs. wild type individuals in an insecticide-free environment) to maintain resistant alleles at low frequencies (reviewed in ). Essentially used for malaria control, fungi also represent promising tools because they kill mosquitoes at slower rate than insecticides thus reducing the risk of resistance selection , , . Here we propose an alternative approach based on the development of "resistant killer" compounds, capable of preferentially inhibiting targets already insensitive to a given insecticide class. Combined with the fitness cost already associated with resistance, populations treated with such "resistant killers" are thus expected to regain a high frequency of susceptible wild type alleles, a "hit where it already hurts" strategy. Ideally, the targeted protein should be highly constrained structurally to minimize its capacity to evolve through the selection of new mutations that would confer resistance to both the insecticide and the "resistant killer" compound.
A good candidate is acetylcholinesterase (AChE, EC 184.108.40.206), which in Coelomates acts as a synaptic terminator of nerve impulses through hydrolysis of the neurotransmitter acetylcholine. Mosquitoes contain two AChE genes (ace-1 and ace-2), ace-1 encoding the synaptic enzyme , . So far, only three substitutions on residues lining the catalytic site confer OP and CX insensitivity to AChE1: the F331W substitution (amino-acid numbering according to the Torpedo californica AChE nomenclature ), found only in Culex tritaeniorhynchus , , the F290V substitution, found only in C. pipiens species , and the universally found G119S substitution, which confers the highest level of insensitivity to a broad range of insecticides and was selected independently in several Culex and Anopheles species (C. pipiens pipiens, C. pipiens quinquefasciatus, C. vishnui, A. gambiae and A. albimanus, , , , ). The G119S-substituted AChE1 appeared as a suitable candidate for the development of reverser compounds because AChE are highly structurally constrained  and the G119S mutation is widely distributed worldwide in mosquitoes and associated with a substantial fitness cost in insecticide-free areas , , , , . This AChE1 constraint constitutes a weakness in its adaptive capacity that might be used to develop innovative resistance management strategies: an insecticide targeting specifically the G119S AChE1 should efficiently reduce the frequency of the resistance allele, while the probability of OP-resistant mosquitoes developing a secondary resistance to the new insecticide is predicted to be quite low. To address the feasibility of this approach, compounds were screened for their capacity to inhibit more efficiently the G119S-substituted (OP-insensitive) AChE1 than the wild type (WT) AChE1. Further biochemical analysis, bioassays on mosquito larvae from susceptible and resistant A. gambiae and C. pipiens strains sharing the same genetic background, as well as gene population modeling show that application of compounds with such properties is predicted to rapidly restore OP susceptibility in field populations.
Identification of Inhibitors of the OP-insensitive G119S AChE1
To identify inhibitors of G119S AChE1, we screened a 3,000-compound chemical library using an assay adapted to a microplate format , . Nine compounds reduced the apparent hydrolysis of the acetylthiocholine substrate, of which one gave an 80–87% inhibition. The core structure of this compound is made of a heterocyclic 2,4,6-pyrimidinetrione (barbituric acid) substituted by a furan cycle (Figure 1A). To improve the efficacy, 71 commercial analogs sharing the core structure with various substitutions on R1, R2, R3, Q1 and Q2 positions were assayed (Figure 1B). For simplification, these compounds will be termed from now as PTF (PyrimidineTrione Furan-substituted) and were classified depending on the substituted positions (Table S1). PTFs exhibited a broad IC50 range on WT and G119S AChE1 (Table S1), from 0.23 µM to 4.5 mM. When sorted by their relative efficacy toward the G119S AChE1 (Table 1), 31 analogs had a RIC50 (ratio of the mean IC50 on WT over the mean IC50 on G119S AChE1) above that of the hit compound (PTF-24, RIC50 = 0.7). Seven analogs had a RIC50 above 10, indicating a much higher efficacy toward G119S AChE1 than OP-sensitive AChE1. Six among the most efficient and specific PTFs (in bold, Table 1) also showed preferential inhibition on other types of OP-insensitive AChE1 (F290V and F331W substitutions) (Table S2). Last, PTFs behaved as reversible and competitive inhibitors; Loss of inhibition after dilution of the enzyme-inhibitor complex indicates that PTFs do not bind covalently to AChE1 (Figure S1); Plotting 1/v (Dixon plots) and [S]/v (Cornish-Bowden plots) against inhibitor concentration (Figure S2) indicates that inhibition is competitive since for various substrate concentrations, the enzyme maximal velocity Vmax did not vary (panels A and B) and [S]/v lines were parallel (panels C and D). Comparison of dissociation constants of the enzyme inhibitor complexes (Kic) confirmed the preferential binding to the OP-insensitive AChE1 (Table S3).
R1 is a hydrogen atom or a methyl group, R2, a methyl group or a substituted aryl group, R3, mostly oxygen or sulfur atoms, except for two compounds having a N atom or a substituted nitrogen group. Q1 is oxygen or sulfur atoms and Q2 is a variable chemical group.
PTF insecticide activity on OP-susceptible and resistant strains.
The 71 analogs were screened for their toxicity on OP-susceptible (Slab strain) or OP-resistant (SR stain) C. pipiens larvae. As a first approach, each PTF was applied at 300 µM for 24 hours (Table S1). Sixteen PTFs were at least 50% more efficient on OP-resistant larvae (ratio Rm300 of mortality of SR larvae over mortality of Slab larvae above 1.5 in Table 1), among which thirteen were also selective as biochemical inhibitors (RIC50 ratios above 1.5, Table 1). We ensured that the mortality induced by PTFs was associated with AChE1 inhibition by measuring the residual AChE1 activity in killed C. pipiens SR larvae (Figure 2). Exposure to PTFs elicited a 55 to 70% reduction in AChE1 activity, within the range of that elicited by exposure to chlorpyrifos (75%), at a dose where it kills OP-resistant larvae through AChE1 inhibition. This demonstrates that PTF larvicidal activity is a consequence of in vivo AChE1 inhibition. To investigate further the larvicidal activities of PTFs, bioassays were performed on OP-resistant and OP-susceptible C. pipiens and A. gambiae larvae (Table 2). PTF-3, -10, -20, -25, -29 and -39 had LD50 ranging from 70.1 to 398.8 µM on OP-resistant C. pipiens larvae (SR strain) and from 160.7 to 964 µM on susceptible ones (Slab strain), with RLD50 (ratio of the mean LD50 on susceptible strain over the mean LD50 on resistant strain) ranging from 1.5 to 3.9. Anopheles gambiae had a similar pattern of susceptibility: PTFs preferentially killed OP-resistant larvae (Acerkis strain), with RLD50 values ranging from 1.3 to 7.7. Each PTF showed species-specific toxicity, but to our knowledge, PTFs are the only molecules that display a higher toxicity on OP-resistant G119S strains than on susceptible strains, both in C. pipiens and in A. gambiae.
C. pipiens larvae from the OP-resistant SR strain were exposed to 300 µM PTF until death and then AChE1 residual activity was measured. Chlorpyrifos (Chlpy) and propoxur (Prpx) were used as positive and negative control inhibitors, respectively. Means and standard errors for three independent experiments are shown.
To determine the dominance of the larvicidal activity of PTFs against ace-1 alleles, six PTFs were tested on heterozygous (ace-1R/ace-1S) larvae produced by a cross between Slab and SR strains, and also on the C. pipiens Ducos strain, harboring the duplicated ace-1 allele in which one ace-1S and one ace-1R copy are arranged in tandem at the homozygous state ). Although the Ducos strain showed slightly less susceptibility, all PTFs tested showed a similar efficacy on [R/S] heterozygotes phenotypes compared to [R/R] homozygotes larvae, indicating dominance of the OP-insensitive ace-1R allele (Table 2).
PTFs as predicted to restore OP-susceptibility.
To examine what would be the impact of PTFs or compounds of similar properties on the evolution of the frequency of resistant alleles in natural populations, we ran a simulation in which the initial infinite and panmictic population contained 10% of OP-sensitive allele (ace-1S), a situation already observed in several OP-treated areas , , , and in which there was no migration. PTF doses were fixed at LD50 for SR larvae and used a r ratio (mortality of resistant ace-1R over that of susceptible ace-1S homozygotes) ranging from 1.2 to 6.0 (i.e. within the range of Rm300 or RLD50 measured for the six PTFs in Tables 1 and 2), and up to 100. We also examined the extreme situations where the ace-1R allele is recessive (i.e. heterozygotes have the same susceptibility to the inhibitor as ace-1S homozygotes) or dominant (ace-1R dominant, i.e. heterozygotes have the same susceptibility to the inhibitor as ace-1R homozygotes).
Under the recessive model (d = 0, Figure 3A), ace-1R frequency (p) decreases rapidly even at r = 1.2 (p = 0.4 after 27 generations). Increasing r up to 6 accelerates the process (p = 0.4 after only 10 generations), while higher values do not improve it significantly further: the ace-1R allele is indeed rapidly restricted to heterozygotes, weakly susceptible to inhibitors with high r-values. Under this scenario, the OP-resistant allele remains in the population, albeit at low frequency, even after 50 generations. Under the dominant model (d = 1, Figure 3B), ace-1R frequency p is more sensitive to r, as it is not silent in heterozygotes: p decreases at a slow rate for r below 1.5 and at a much faster rate for r above 2. As for recessivity, increasing r beyond 6 has minor effects on the decrease rate of ace-1R, but in contrast, ace-1R is eliminated from the population in less than 50 generations if r ≥1.5. As shown in the insets of panels A and B, the percentage of individuals killed at each generation (i.e. the efficacy of vector control) is only significantly reduced for toxicity ratios r above 2. This occurs after 10 to 30 generations depending on the dominance type, since global mortality during the first generations is mostly driven by the initial ace-1R frequency (p0 = 0.9) and the mortality rate of ace-1R homozygotes (m = 0.5, i.e. at LD50 dose).
Evolution of an OP-resistant, infinite and panmictic population treated with PTFs was computed as described in Material and Methods. The ace-1R initial frequency was 0.9 and PTF compounds were applied at LD50 for ace-1R homozygotes (i.e. m = 0.5). r represents the mortality ratio of ace-1R vs. ace-1S homozygotes. Panel A represents the evolution of ace-1R frequency when this allele is recessive (d = 0) and panel B, when it is dominant (d = 1). Curves represent the evolution of ace-1R frequency across generations for various PTF mortality r ratios between 1.2 and 100. Insets represent the proportion of individuals killed at each generation.
In conclusion, this model shows that treating populations with PTF compounds allows to regain OP-susceptibility; PTF application to populations with high OP-resistance allele frequency should lead in a few generations to both significant mortality and decrease in OP-resistant alleles frequency.
We show here that PTFs qualify as a new class of reversible and competitive AChE1 inhibitors, with preferential efficacy toward OP-insensitive AChE1 in vitro and OP-resistant C. pipiens or A. gambiae mosquito larvae in vivo.
The fact that PTFs behave as reversible and competitive AChE1 inhibitors strongly suggests that they target the docking sites for acetylcholine, i.e. the peripheral (P-) or the active (A-) sites . Furthermore, PTFs preferentially inhibit all OP-insensitive mutants (G119S, F290V, F331W), whose substituted positions line the A-site and are thought to confer OP-insensitivity by steric hindrance , . It is therefore unlikely that PTFs can freely enter the A-site of OP-insensitive enzymes and a more likely hypothesis is that PTFs bind on top of the A- or the P-site, thereby blocking access to the substrate to either site. This agrees with the absence of correlation between PTF efficacy and specific chemical groups at the R1, R2 or R3 positions, suggesting that docking of the core PTF structure to its target might be stabilized through multiple interactions with neighboring residues. Availability of AChE1 three-dimensional structure, alone or in complex with PTFs, should help understand the structural basis of the interaction.
PTFs proved to be efficient in vivo on C. pipiens and A. gambiae larvae and showed similar selectivity toward OP-resistant larvae, although with different RLD50 values. Behavioral or physiological differences might account for this difference; Anopheles gambiae larvae are surface filter-feeders while C. pipiens are deeper filter-feeders that regularly swim up to breathe . Previous work also demonstrated that the dominance of resistance in C. pipiens varies with environment, such as food, water quality and shape of the cups used in bioassays . All these parameters might impact on insecticide uptake or induced mortality.
Since PTFs inhibit all types of OP-insensitive AChE1 in vitro, i.e. G119S-, F290V- or F331W-substituted, this strongly suggests that PTF molecules might exhibit a broad larvicidal spectrum toward most OP-resistant field populations. Availability of PTFs as a new insecticide class directed against OP-insensitive AChE1 represents a major advance for the development of sustainable insecticide resistance management strategies for three main reasons:
- PTF-like compounds are expected to efficiently control populations with high OP-resistant allele frequencies while reducing the risk of selecting resistance alleles other than the wild type. Indeed, AChE1 is a structurally highly constrained protein and the G119S substitution conferring OP-resistance has substantially reduced its enzymatic activity . Occurrence of an additional substitution on the OP-insensitive backbone is thus likely to further decrease AChE1 activity below the required physiological levels.
- Modeling the impact of PTFs on an OP-resistant population indicates that even moderate selectivity (r = 1.5 to 3) is sufficient to significantly decrease the frequency of OP-resistant alleles (i.e. effective resistance control) in just a few generations. PTF-treated populations might therefore rapidly regain OP-susceptibility and be subsequently controlled by OPs at much lower doses. Used in rotation, PTFs and OPs would thus be complementary tools for controlling mosquito populations and managing resistance in a more sustainable way.
- Compounds that target OP-sensitive and insensitive AChE1 might also prove very effective on populations that have selected for ace-1 duplication, associating a wild type and a resistant G119S allele, like in C. pipiens and A. gambiae populations heavily controlled by insecticides , , . This duplication was shown to partially compensate for the fitness cost associated with mutated AChE1, probably by restoring cholinergic activity close to physiological levels . Interestingly, the ace-1R allele appeared mostly dominant toward PTF in a context where both G119S and WT AChE1 forms are present [i.e. Ducos strain (ace-1D) or (ace-1R/ace-1S) heterozygotes, Table 2]. According to the model predictions, this further supports the use of PTFs for rapidly decreasing the frequency of ace-1R in OP-resistant populations.
In conclusion, this study validates an innovative approach for resistance management of mosquito vectors, based on the development of molecules targeting preferentially enzymes already insensitive to currently used insecticides. PTFs identified here behave as preferential inhibitors of AChE1 mutants insensitive to OP and CX and as preferential killers of OP-resistant C. pipiens and A. gambiae larvae in bioassays. This approach should allow both efficient vector and resistance control management: The preferential killing of resistant mosquitoes mimics a situation of negative cross-resistance, in which frequency of resistance alleles decreases much faster than when insecticides acting on other targets are used. Furthermore, since wild type OP-susceptible alleles are, by construction, PTF-resistant alleles, odds are against the selection of other resistance events. Wild type alleles are indeed more frequent than any spontaneous mutant and are associated with the highest fitness. Although not easily amenable to high throughput screening, voltage-gated sodium channels represent other interesting candidates for developing a similar strategy; they are targets of pyrethroids, the major insecticide class currently used in malaria control; resistance to pyrethroids is spreading in many species through the selection of a very small number of insensitive alleles (particularly kdr-west, kdr-east), affecting the same amino acid 1014 (house fly numbering) , . This strategy could also be applied to any pest that acquired resistance through one or a few mutations in a structurally constrained target for which resistance is associated with a fitness cost.
Developing new approaches to maintain vector control and maximize the effective lifespan of current and future insecticides is one of the objectives of the Global Plan for Insecticide Resistance Management (WHO 2012). This aim is paramount in a context where more than 500 arthropod species (either medical or agricultural pests) have become resistant to most if not all currently used insecticides . The present study demonstrates that a "hit where it already hurts" strategy could fit the bill.
Materials and Methods
All chemical compounds were purchased from ChemBridge (San Diego, CA, USA), except eserine, from Sigma-Aldrich, (Saint-Louis, USA), propoxur, from Bayer (Leverkusen, Germany), chlorpyrifos, from CIL Luzeau (France) and tacrine, from ICN Biomedicals, Inc (Eschwege, Germany).
Three C. pipiens strains were used: the susceptible reference Slab strain, homozygous for ace-1S , the resistant reference SR strain, carrying the genetical background of Slab but homozygous for the G119S mutation, allele ace-1R  and the Ducos strain, carrying the genetical background of Slab but homozygous for an ace-1 duplication, with one ace-1S and ace-1R copy in tandem . Culex pipiens heterozygous larvae (Slab×SR) were obtained by crossing Slab males and SR females. Two A. gambiae reference strains (S molecular form) were used: the susceptible strain Kisumu, homozygous for ace-1S, collected in Kenya in 1953 and maintained since then under laboratory conditions  and the resistant Acerkis strain, carrying the genetical background of Kisumu but homozygous for an ace-1R allele from a population collected in Bobo-Dioulasso, Burkina Faso .
AChE Assays and Screening Procedures
Production of C. pipiens WT and mutated AChE1s in Drosophila S2 cells was already described . The chemical library (ChemBridge, 3,000 compounds) screening was performed in duplicate on G119S recombinant AChE1. Chemicals were made soluble in ethanol or dimethylsulphoxide (DMSO), and then diluted at 300 µM in ethanol for storage. Compounds (30 µM final concentration) were incubated for 15 min at room temperature with 100 µl of G119S recombinant AChE1 then 100 µl of substrate (acetylthiocholine, 1.6 mM, Sigma-Aldrich) was added and the residual activity was quantified by measuring the optical density at 412 nm, as described by Ellman et al. . PTF analogs were analyzed in dose-response experiments (10-fold serial dilutions from 3 mM to 30 nM), using recombinant WT and G119S AChE1 or mosquito head extracts (heads cut from frozen mosquitoes, homogenized in 400 µl PB containing 1% Triton X-100 and cleared by centrifugation at 9,000×g for 3 min). Depending on compound availability, two to five replicates were performed with distinct batches of enzyme. Concentrations producing 50% enzyme inhibition (IC50) were determined using regression analysis of log-concentrations versus percentage inhibitions. IC50 was estimated by nonlinear least square regression. IC50 was also measured on AChE1 from susceptible and resistant mosquito larvae extracts.
To address the residual AChE1 activity after exposure to 300 µM PTF, larvae were collected as soon as mortality was reached to avoid AChE1 degradation. Larvae were rinsed twice with distilled water and homogenized individually in 400 µl PB containing 1% Triton X-100. Homogenates were centrifuged at 9,000×g for 3 min and assayed for AChE1 activity as described above.
Insecticidal activity was determined by performing bioassays on fourth-instar larvae as described in . Each compound was dissolved in ethanol. Propoxur (CX) and chlorpyrifos (OP) were used as references. For each compound, we first tested mortality after a 24-hour exposure at 300 µM. For the most selective compounds and depending on their availability, three to five replicates at four different concentrations were performed on C. pipiens and A. gambiae strains. Mortality data were analyzed by the log-probit program . This program takes into account natural mortality and provides lethal doses (LD) and slopes for each mortality line; it also computes resistance ratios (RR) for each LD, with 95% confidence intervals.
Modeling PTF Treatment of OP-resistant Populations
The evolution at each generation i of pi, the frequency of the OP-resistant allele (named ace-1R), and Ni, the proportion of the population killed by insecticide, were modeled in an infinite population under panmixia (Hardy-Weinberg equilibrium). Let m be the mortality rate for the ace-1R homozygotes and m/r the mortality for the ace-1S homozygotes, r being the toxicity ratio specific for each PTF (i.e. the ratio of the mortality of ace-1R homozygotes over the mortality of ace-1S homozygotes for a given dose of a given PTF). Let d be the dominance of ace-1R over ace-1S in heterozygotes treated with PTF: d = 1 and d = 0 indicate, respectively, that the mortality of the heterozygotes is equal to that of the ace-1R homozygotes or to that of the ace-1S homozygotes; dominance is intermediate when 0< d <1. At generation i, PTF treatment kills a proportion.
Reversibility of PTF inhibition. Reversibility was tested using a rapid dilution procedure. Residual activity of WT (white bars) and G119S (grey bars) AChE1 were measured after 15 min incubation in presence of inhibitors (striped bars) and are expressed as percentages of control activity. Tacrine and chlorpyrifos-oxon were used as references for reversible and irreversible inhibition, respectively. Inhibitor concentrations were 150 µM of PTF-29 for both WT and G119S AChE1, 5 and 100 µM of chlorpyrifos-oxon respectively for WT and G119S AChE1, and 5 and 50 µM tacrine respectively for WT and G119S AChE1. Assays were then diluted ten times and residual activity was measured (open bars). Means and standard errors for three independent experiments are shown.
PTF inhibition is competitive. WT and G119S recombinant AChE1s were incubated with 0.25 mM, 0.5 mM or 1 mM inhibitor. Residual activity of G119S (A and C) and WT (B and D) AChE1 was measured in the presence of various concentrations of PTF-20 and substrates. Enzymatic activity was analyzed using the graphical method developed by Dixon , representing reciprocal rates (1/v) (A and B) or reciprocal rates multiplied by substrate concentrations ([S]/v) (C and D) as a function of inhibitor concentration.
Properties of PTF analogs.
Activities of PTFs on G119S, F290V and F331W OP-insensitive AChE1.
Dissociation constant (K ic ) of the enzyme-inhibitor complex.
We thank Nicole Pasteur for valuable comments and discussions during manuscript preparation, and Julian Venables for critical reading of the manuscript. We are very grateful to C. Bernard, S. Unal and P. Makoundou for technical assistance and F. Chandre for providing A. gambiae larvae.
Conceived and designed the experiments: HA J-PL PF MW. Performed the experiments: HA PL AB MW. Analyzed the data: HA PL J-PL PF MW. Contributed reagents/materials/analysis tools: J-PL LD MW. Wrote the paper: HA PL PF MW.
- 1. Casida JE, Quistad GB (2004) Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 17: 983–998. doi: 10.1021/tx0499259
- 2. Rodcharoen J, Mulla MS (1996) Cross-resistance to Bacillus sphaericus strains in Culex quinquefasciatus. J Am Mosq Control Assoc 12: 247–250.
- 3. Li AY, Guerrero FD, Almazan Garcia C, George JE (2003) Survey of resistance to permethrin and diazinon and the use of a multiplex polymerase chain reaction assay to detect resistance alleles in the horn fly, Haematobia irritans irritans (L.). J Med Entomol 40: 942–949. doi: 10.1603/0022-2585-40.6.942
- 4. Li X, Schuler MA, Berenbaum MR (2007) Molecular mechanisms of metabolic resistance to synthetic and natural xenobiotics. Annu Rev Entomol 52: 231–253. doi: 10.1146/annurev.ento.51.110104.151104
- 5. Brogdon WG, McAllister JC (2004) Insecticide resistance and vector control. J Agromedicine 9: 329–345. doi: 10.1300/j096v06n02_04
- 6. Enayati A, Hemingway J (2010) Malaria management: past, present, and future. Annu Rev Entomol 55: 569–591. doi: 10.1146/annurev-ento-112408-085423
- 7. Gassmann AJ, Onstad DW, Pittendrigh BR (2009) Evolutionary analysis of herbivorous insects in natural and agricultural environments. Pest Manag Sci 65: 1174–1181. doi: 10.1002/ps.1844
- 8. Farenhorst M, Mouatcho JC, Kikankie CK, Brooke BD, Hunt RH, et al. (2009) Fungal infection counters insecticide resistance in African malaria mosquitoes. Proc Natl Acad Sci U S A 106: 17443–17447. doi: 10.1073/pnas.0908530106
- 9. Michalakis Y, Renaud F (2009) Malaria: Evolution in vector control. Nature 462: 298–300. doi: 10.1038/462298a
- 10. Read AF, Lynch PA, Thomas MB (2009) How to make evolution-proof insecticides for malaria control. PLoS Biol 7: e1000058. doi: 10.1371/journal.pbio.1000058
- 11. Huchard E, Martinez M, Alout H, Douzery EJ, Lutfalla G, et al. (2006) Acetylcholinesterase genes within the Diptera: takeover and loss in true flies. Proc Biol Sci 273: 2595–2604. doi: 10.1098/rspb.2006.3621
- 12. Weill M, Fort P, Berthomieu A, Dubois MP, Pasteur N, et al. (2002) A novel acetylcholinesterase gene in mosquitoes codes for the insecticide target and is non-homologous to the ace gene in Drosophila. Proc Biol Sci 269: 2007–2016. doi: 10.1098/rspb.2002.2122
- 13. Alout H, Berthomieu A, Hadjivassilis A, Weill M (2007) A new amino-acid substitution in acetylcholinesterase 1 confers insecticide resistance to Culex pipiens mosquitoes from Cyprus. Insect Biochem Mol Biol 37: 41–47. doi: 10.1016/j.ibmb.2006.10.001
- 14. Nabeshima T, Mori A, Kozaki T, Iwata Y, Hidoh O, et al. (2004) An amino acid substitution attributable to insecticide-insensitivity of acetylcholinesterase in a Japanese encephalitis vector mosquito, Culex tritaeniorhynchus. Biochem Biophys Res Commun 313: 794–801. doi: 10.1016/j.bbrc.2003.11.141
- 15. Alout H, Berthomieu A, Cui F, Tan Y, Berticat C, et al. (2007) Different amino-acid substitutions confer insecticide resistance through acetylcholinesterase 1 insensitivity in Culex vishnui and Culex tritaeniorhynchus (Diptera: Culicidae) from China. J Med Entomol 44: 463–469. doi: 10.1603/0022-2585(2007)44[463:dascir]2.0.co;2
- 16. Cui F, Raymond M, Berthomieu A, Alout H, Weill M, et al. (2006) Recent emergence of insensitive acetylcholinesterase in Chinese populations of the mosquito Culex pipiens (Diptera: Culicidae). J Med Entomol 43: 878–883. doi: 10.1603/0022-2585(2006)43[878:reoiai]2.0.co;2
- 17. eill M, Lutfalla G, Mogensen K, Chandre F, Berthomieu A, et al. (2003) Comparative genomics: Insecticide resistance in mosquito vectors. Nature 423: 136–137. doi: 10.1038/423136b
- 18. Weill M, Malcolm C, Chandre F, Mogensen K, Berthomieu A, et al. (2004) The unique mutation in ace-1 giving high insecticide resistance is easily detectable in mosquito vectors. Insect Mol Biol 13: 1–7. doi: 10.1111/j.1365-2583.2004.00452.x
- 19. Oakeshott JG, Devonshire AL, Claudianos C, Sutherland TD, Horne I, et al. (2005) Comparing the organophosphorus and carbamate insecticide resistance mutations in cholin- and carboxyl-esterases. Chem Biol Interact 157–158: 269–275. doi: 10.1016/j.cbi.2005.10.041
- 20. Berticat C, Boquien G, Raymond M, Chevillon C (2002) Insecticide resistance genes induce a mating competition cost in Culex pipiens mosquitoes. Genet Res 79: 41–47. doi: 10.1017/s001667230100547x
- 21. Berticat C, Duron O, Heyse D, Raymond M (2004) Insecticide resistance genes confer a predation cost on mosquitoes, Culex pipiens. Genet Res 83: 189–196. doi: 10.1017/s0016672304006792
- 22. Berticat C, Rousset F, Raymond M, Berthomieu A, Weill M (2002) High Wolbachia density in insecticide-resistant mosquitoes. Proc Biol Sci 269: 1413–1416. doi: 10.1098/rspb.2002.2022
- 23. Duron O, Labbe P, Berticat C, Rousset F, Guillot S, et al. (2006) High Wolbachia density correlates with cost of infection for insecticide resistant Culex pipiens mosquitoes. Evolution 60: 303–314. doi: 10.1554/05-340.1
- 24. Raymond M, Berticat C, Weill M, Pasteur N, Chevillon C (2001) Insecticide resistance in the mosquito culex pipiens: what have we learned about adaptation? Genetica 112–113: 287–296. doi: 10.1007/978-94-010-0585-2_18
- 25. Bourguet D, Pasteur N, Bisset J, Raymond M (1996) Determination of Ace.1 Genotypes in Single Mosquitoes: Toward an Ecumenical Biochemical Test. Pestic Biochem Physiol 55: 122–128. doi: 10.1006/pest.1996.0041
- 26. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95. doi: 10.1016/0006-2952(61)90145-9
- 27. Labbe P, Berthomieu A, Berticat C, Alout H, Raymond M, et al. (2007) Independent duplications of the acetylcholinesterase gene conferring insecticide resistance in the mosquito Culex pipiens. Mol Biol Evol 24: 1056–1067. doi: 10.1093/molbev/msm025
- 28. Labbe P, Berticat C, Berthomieu A, Unal S, Bernard C, et al. (2007) Forty years of erratic insecticide resistance evolution in the mosquito Culex pipiens. PLoS Genet 3: e205. doi: 10.1371/journal.pgen.0030205
- 29. Yebakima A, Marquine M, Rosine J, Yp-Tcha MM, Pasteur N (2004) Evolution of resistance under insecticide selection pressure in Culex pipiens quinquefasciatus (Diptera, Culicidae) from Martinique. J Med Entomol 41: 718–725. doi: 10.1603/0022-2585-41.4.718
- 30. Ben Cheikh R, Berticat C, Berthomieu A, Pasteur N, Ben Cheikh H, et al. (2009) Genes conferring resistance to organophosphorus insecticides in Culex pipiens (Diptera: Culicidae) from Tunisia. J Med Entomol 46: 523–530. doi: 10.1603/033.046.0317
- 31. Alout H, Djogbenou L, Berticat C, Chandre F, Weill M (2008) Comparison of Anopheles gambiae and Culex pipiens acetycholinesterase 1 biochemical properties. Comp Biochem Physiol B Biochem Mol Biol 150: 271–277. doi: 10.1016/j.cbpb.2008.03.008
- 32. Merritt RW, Dadd RH, Walker ED (1992) Feeding behavior, natural food, and nutritional relationships of larval mosquitoes. Annu Rev Entomol 37: 349–376. doi: 10.1146/annurev.en.37.010192.002025
- 33. Bourguet D, Capela R, Raymond M (1996) An insensitive acetylcholinesterase in Culex pipiens (Diptera:Culicidae) from Portugal. J Econ Entomol 89: 1060–1066.
- 34. lout H, Weill M (2008) Amino-acid substitutions in acetylcholinesterase 1 involved in insecticide resistance in mosquitoes. Chem Biol Interact 175: 138–141. doi: 10.1016/j.cbi.2008.03.018
- 35. Djogbenou L, Chandre F, Berthomieu A, Dabire R, Koffi A, et al. (2008) Evidence of introgression of the ace-1(R) mutation and of the ace-1 duplication in West African Anopheles gambiae s. s. PLoS One 3: e2172. doi: 10.1371/journal.pone.0002172
- 36. Martinez-Torres D, Chandre F, Williamson MS, Darriet F, Berge JB, et al. (1998) Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s. Insect Mol Biol 7: 179–184. doi: 10.1046/j.1365-2583.1998.72062.x
- 37. Ranson H, Jensen B, Vulule JM, Wang X, Hemingway J, et al. (2000) Identification of a point mutation in the voltage-gated sodium channel gene of Kenyan Anopheles gambiae associated with resistance to DDT and pyrethroids. Insect Mol Biol 9: 491–497. doi: 10.1046/j.1365-2583.2000.00209.x
- 38. Kelly-Hope L, Ranson H, Hemingway J (2008) Lessons from the past: managing insecticide resistance in malaria control and eradication programmes. Lancet Infect Dis 8: 387–389. doi: 10.1016/s1473-3099(08)70045-8
- 39. Georghiou GP, Metcalf RL, Gidden FE (1966) Carbamate-resistance in mosquitos. Selection of Culex pipiens fatigans Wiedemann ( = C. quinquefasciatus Say) for resistance to Baygon. Bull World Health Organ 35: 691–708.
- 40. Shute D (1956) A method of maintaining colonies of East African strains of Anopheles gambiae. Annals of Tropical Medecine and Parasitology 50: 92–94.
- 41. Djogbenou L, Weill M, Hougard JM, Raymond M, Akogbeto M, et al. (2007) Characterization of insensitive acetylcholinesterase (ace-1R) in Anopheles gambiae (Diptera: Culicidae): resistance levels and dominance. J Med Entomol 44: 805–810. doi: 10.1603/0022-2585(2007)44[805:coiaai]2.0.co;2
- 42. Rivet Y, Raymond M, Rioux JA, Delalbre A, Pasteur N (1994) Resistance monitoring in Culex pipiens (Diptera: Culicidae) from central-eastern France. J Med Entomol 31: 231–239.
- 43. Raymond M, Prato G, Ratsira D (1997) Probit analysis of mortality assays displaying quantal responses. Licence CNRS-UM2, L93019. 2.0 ed. St. Georges d'Orques, France: Praxème.
- 44. Dixon M (1953) The determination of enzyme inhibitor constants. Biochem J 55: 170–171.